NET PROFIT (x1000 EUR)
Centrum för Andrologi och Urologi i Sverige AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
140
|
202
|
80 |
| EBITDA |
-2
|
-2
|
-2 |
| Total assets |
798
|
799
|
876 |
| Current assets |
84
|
81
|
75 |
| Current liabilities |
119
|
190
|
359 |
| Equity capital |
642
|
574
|
479 |
| - share capital |
5
|
4
|
5 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
80.5%
|
71.8%
|
54.7% |
| Turnover per employee | |||
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
17.5%
|
25.3%
|
9.1% |
| Current ratio |
70.6%
|
42.6%
|
20.9% |
| Return on equity (ROE) |
21.8%
|
35.2%
|
16.7% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.